ValueConnected

Over ValueConnected

A medical technology launch in Europe is not one market access project. It is many.

Germany decides through the G-BA and the NUB/DRG system. France decides through HAS's CNEDiMTS. The UK through NICE and NHS commissioning. The Nordics, Italy, Spain, and the Benelux each add their own logic, evidence expectations, and timelines. Cross the Atlantic to Brazil, and you face CONITEC for the public system and ANS for the private one — a public-private structure unlike any in Europe. And in the US, CMS payment policy is redrawing the map for breakthrough technologies: coverage is accelerating while the payment bar rises, and the evidence that satisfies one no longer guarantees the other.

Most companies re-learn each system with every launch — different local consultancies, different quality standards, different answers.

ValueConnected covers the payer systems in your launch plan with a single methodology and a single senior team — the team that sells the work does the work. European by origin and by standard, with US and Latin American reach through our local offices. ISO 9001-certified. Senior-only delivery.

Value Leading Strategy, our value-demonstration methodology, is the same across every system. The evidence requirements change. The discipline doesn't.

Trefwoorden

• Ai
• Commercialization
• Diagnostics
• Digital Health
• Go-To-Market
• Health Economics
• Market Access
• Market Assessment
• Medical Devices
• Reimbursement Strategy
• Strategy
• Value Communication
• Value Demonstration
• Value-Based Healthcare

Adres

• Hoofdkantoor

  Prinses Margrietplantsoen 332595AM Den HaagZuid-Holland, Nederland

Team per functiegebied

Gebaseerd op 2 openbare functieprofielen, stand van 2 september 2026.

• Administrative / Office1
• Founder / Owner1